Monocyclic and bicyclic compounds and methods of use
申请人:Zhang Penglie
公开号:US20070066583A1
公开(公告)日:2007-03-22
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.